Polypharmacy and Hyperpolypharmacy in Older Individuals with Parkinson ’s Disease: A Systematic Review and Meta-Analysis

Conclusion: Polypharmacy (40%) and hyperpolypharmacy (18%) are highly prevalent and eventually increase the risk of drug-related problems in older adults with PD. Therefore, interventions that ensure rational geriatric pharmacotherapy are of critical importance for the older population with neurogenerative disorders.Gerontology
Source: Gerontology - Category: Geriatrics Source Type: research